An Overview of the MA17R Trial in Breast Cancer

Video

Frankie Ann Holmes, MD, medical oncologist, Texas Oncology, discusses the implications of the results of the MA17R trial, which is a randomized phase III clinical trial that examined the benefits of extending aromatase inhibitors with letrozole as a treatment for postmenopausal patients with early breast cancer.

Recent Videos
3 KOLs are featured in this series.
Related Content